Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis. Mohs A, Otto T, Schneider KM, Peltzer M, et al. J Hepatol 2020 Oct 24. pii: S0168-8278(20)33695.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mohs A, Otto T, Schneider KM, Peltzer M, et al. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis. J Hepatol 2020 Oct 24. pii: S0168-8278(20)33695.
PMID: 33342543